- Home
- MIST vs TLSA Comparison
MIST vs TLSA Comparison
Compare MIST & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- TLSA
- Stock Information
- Founded
- MIST 2003
- TLSA 2013
- Country
- MIST Canada
- TLSA United Kingdom
- Employees
- MIST N/A
- TLSA N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- MIST Health Care
- TLSA Health Care
- Exchange
- MIST Nasdaq
- TLSA Nasdaq
- Market Cap
- MIST 81.5M
- TLSA 87.8M
- IPO Year
- MIST N/A
- TLSA 2000
- Fundamental
- Price
- MIST $1.43
- TLSA $1.20
- Analyst Decision
- MIST Strong Buy
- TLSA
- Analyst Count
- MIST 3
- TLSA 0
- Target Price
- MIST $13.00
- TLSA N/A
- AVG Volume (30 Days)
- MIST 177.8K
- TLSA 145.8K
- Earning Date
- MIST 11-11-2024
- TLSA 05-10-2024
- Dividend Yield
- MIST N/A
- TLSA N/A
- EPS Growth
- MIST N/A
- TLSA N/A
- EPS
- MIST N/A
- TLSA N/A
- Revenue
- MIST N/A
- TLSA N/A
- Revenue This Year
- MIST N/A
- TLSA N/A
- Revenue Next Year
- MIST N/A
- TLSA N/A
- P/E Ratio
- MIST N/A
- TLSA N/A
- Revenue Growth
- MIST N/A
- TLSA N/A
- 52 Week Low
- MIST $1.12
- TLSA $0.41
- 52 Week High
- MIST $3.52
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- MIST 42.50
- TLSA 65.44
- Support Level
- MIST $1.41
- TLSA $0.83
- Resistance Level
- MIST $1.53
- TLSA $0.92
- Average True Range (ATR)
- MIST 0.07
- TLSA 0.09
- MACD
- MIST -0.01
- TLSA 0.03
- Stochastic Oscillator
- MIST 26.96
- TLSA 84.52
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.